Patent · US Active

Conjugates of fusion proteins of GLP-1 and FGF21

US11510990B2 · kind B2 · utility

0Cited by
47References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 26, 2021
Grant dateNov 29, 2022
Priority date
Expiry dateSep 26, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/915
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides conjugates of polypeptides comprising GLP-1, polypeptide linker and FGF21. Pharmaceutical compositions comprising the same and methods of treating diseases are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.